Macrogen, Inc. (KOSDAQ:038290)

South Korea flag South Korea · Delayed Price · Currency is KRW
16,930
+60 (0.36%)
At close: Dec 5, 2025
2.23%
Market Cap 183.54B
Revenue (ttm) 179.98B
Net Income (ttm) -700.38M
Shares Out 10.84M
EPS (ttm) -65.83
PE Ratio n/a
Forward PE 23.55
Dividend 300.00 (1.78%)
Ex-Dividend Date Dec 29, 2025
Volume 17,879
Average Volume 38,792
Open 16,890
Previous Close 16,870
Day's Range 16,650 - 16,930
52-Week Range 14,700 - 18,000
Beta 0.68
RSI 65.94
Earnings Date Feb 13, 2026

About Macrogen

Macrogen, Inc. provides precision medicine and bio-engineering healthcare services in Korea and internationally. It offers personal healthcare services, including disease prediction and wellness genetic, and DTC genetic testing services; MyPETGENE, a genetic testing service for companion animals; clinical services, such as precision medicine, genetic testing for cancer risk, NGS-based genetic panel lab, and GCLP services; and single cell expert services comprising single cell multi-omics and spatial transcriptome analysis, and single cell (In S... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1997
Employees 500
Stock Exchange KOSDAQ
Ticker Symbol 038290
Full Company Profile

Financial Performance

In 2024, Macrogen's revenue was 135.78 billion, an increase of 2.24% compared to the previous year's 132.80 billion. Losses were -7.60 billion, -54.78% less than in 2023.

Financial Statements

News

There is no news available yet.